Nventa Biopharmaceuticals Corporation

Nventa Biopharmaceuticals Corporation was a Canadian incorporated biopharmaceutical company headquartered in San Diego, California developing therapeutics for the treatment of viral infections and cancer, focusing on diseases caused by human papillomavirus (HPV). Nventa is currently the only company applying heat shock protein (Hsp) technology to target the over 20 million Americans already infected with HPV. Previously headquartered in Victoria, British Columbia, Canada, the company’s common stock traded on the Toronto Stock Exchange under the symbol: NVN.

Read more about Nventa Biopharmaceuticals Corporation:  Development Programs, Clinical Progress, Senior Management, Merger With Akela Pharma, Inc

Famous quotes containing the word corporation:

    “The nearest the modern general or admiral comes to a small-arms encounter of any sort is at a duck hunt in the company of corporation executives at the retreat of Continental Motors, Inc.”
    —C. Wright Mills (1916–1962)